Title |
Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial
|
---|---|
Published in |
BMC Neurology, January 2013
|
DOI | 10.1186/1471-2377-13-11 |
Pubmed ID | |
Authors |
Stefanie Leistner, Georg Michelson, Inga Laumeier, Michael Ahmadi, Maureen Smyth, Gabriele Nieweler, Wolfram Doehner, Jan Sobesky, Jochen B Fiebach, Peter Marx, Otto Busse, Friedrich Köhler, Holger Poppert, Martin LJ Wimmer, Thomas Knoll, Paul Von Weitzel-Mudersbach, Heinrich J Audebert |
Abstract |
Patients with recent stroke or TIA are at high risk for new vascular events. Several evidence based strategies in secondary prevention of stroke are available but frequently underused. Support programs with multifactorial risk factor modifications after stroke or TIA have not been investigated in large-scale prospective controlled trials so far. INSPiRE-TMS is a prospective, multi-center, randomized open intervention trial for intensified secondary prevention after minor stroke and TIA. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Egypt | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Italy | 1 | <1% |
Unknown | 168 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 24 | 14% |
Researcher | 22 | 13% |
Student > Postgraduate | 15 | 9% |
Student > Ph. D. Student | 14 | 8% |
Student > Bachelor | 12 | 7% |
Other | 40 | 23% |
Unknown | 44 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 37% |
Nursing and Health Professions | 21 | 12% |
Psychology | 12 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Neuroscience | 6 | 4% |
Other | 15 | 9% |
Unknown | 47 | 27% |